1. Home
  2. GPK vs ROIV Comparison

GPK vs ROIV Comparison

Compare GPK & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graphic Packaging Holding Company

GPK

Graphic Packaging Holding Company

HOLD

Current Price

$15.16

Market Cap

4.5B

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$22.21

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPK
ROIV
Founded
2007
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
14.1B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
GPK
ROIV
Price
$15.16
$22.21
Analyst Decision
Hold
Strong Buy
Analyst Count
8
8
Target Price
$19.86
$24.31
AVG Volume (30 Days)
5.4M
8.2M
Earning Date
02-03-2026
02-09-2026
Dividend Yield
2.90%
N/A
EPS Growth
N/A
N/A
EPS
1.70
N/A
Revenue
$8,609,000,000.00
$20,329,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$741.42
P/E Ratio
$8.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.93
$8.73
52 Week High
$28.62
$23.47

Technical Indicators

Market Signals
Indicator
GPK
ROIV
Relative Strength Index (RSI) 41.48 58.09
Support Level $14.93 $21.60
Resistance Level $15.85 $22.72
Average True Range (ATR) 0.46 0.82
MACD 0.02 -0.00
Stochastic Oscillator 55.68 61.77

Price Performance

Historical Comparison
GPK
ROIV

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Paperboard Manufacturing, Americas Paperboard Packaging, and Europe Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company generates revenue from the Americas, Europe and Asia Pacific regions.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: